BlackRock Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14K Hold
8,009
﹤0.01% 3531
2016
Q3
$22K Hold
8,009
﹤0.01% 3434
2016
Q2
$19K Sell
8,009
-13,998
-64% -$38.6K ﹤0.01% 3464
2016
Q1
$71K Hold
22,007
﹤0.01% 3068
2015
Q4
$105K Sell
22,007
-8,448
-28% -$47.9K ﹤0.01% 2905
2015
Q3
$169K Sell
30,455
-165
-0.5% -$1.22K ﹤0.01% 2819
2015
Q2
$244K Buy
30,620
+3,318
+12% +$28.5K ﹤0.01% 2687
2015
Q1
$287K Buy
27,302
+4,023
+17% +$55K ﹤0.01% 2472
2014
Q4
$280K Sell
23,279
-1,020
-4% -$15.5K ﹤0.01% 2412
2014
Q3
$415K Sell
24,299
-1,031
-4% -$15K ﹤0.01% 2116
2014
Q2
$306K Sell
25,330
-1,760
-6% -$16.7K ﹤0.01% 2374
2014
Q1
$229K Buy
27,090
+5,755
+27% +$46.4K ﹤0.01% 2566
2013
Q4
$126K Buy
21,335
+1,644
+8% +$8.47K ﹤0.01% 2931
2013
Q3
$107K Buy
19,691
+285
+1% +$1.37K ﹤0.01% 2925
2013
Q2
$79K Buy
+19,406
New +$91.1K ﹤0.01% 3029

Other funds holding BDSI

BlackRock Advisors's BDSI Position: Q4 2016 in Review

BlackRock Advisors held its BioDelivery Sciences International, Inc. (BDSI) position steady in Q4 2016 at 8,009 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3531.

BlackRock Advisors first reported a position in BDSI in Q2 2013 and has held it in 15 quarters since. The position peaked at $415K in Q3 2014. 77 funds tracked by Wall St. Rank hold BDSI as of Q4 2016.

  • BlackRock Advisors held 8,009 shares of BioDelivery Sciences International, Inc. worth $14K as of Q4 2016.
  • BlackRock Advisors left its BioDelivery Sciences International, Inc. share count unchanged in Q4 2016.
  • BioDelivery Sciences International, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3531 holding.
  • BlackRock Advisors first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's BioDelivery Sciences International, Inc. position peaked at $415K in Q3 2014.
  • 77 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.